Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
05:35pm, Sunday, 05'th May 2024
LOS ANGELES, CA / ACCESSWIRE / May 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the
NEW ORLEANS, May 3, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities c
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
12:45pm, Friday, 03'rd May 2024
NEW YORK , May 3, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS)
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
12:11pm, Thursday, 25'th Apr 2024
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most.
SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?
12:41pm, Thursday, 11'th Apr 2024
Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Doximity (DOCS). But which of these two companies is the best option for thos
Down -6.99% in 4 Weeks, Here's Why You Should You Buy the Dip in Doximity (DOCS)
10:36am, Wednesday, 03'rd Apr 2024
The heavy selling pressure might have exhausted for Doximity (DOCS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i
All You Need to Know About Doximity (DOCS) Rating Upgrade to Buy
01:01pm, Thursday, 28'th Mar 2024
Doximity (DOCS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ICLR vs. DOCS: Which Stock Is the Better Value Option?
12:41pm, Thursday, 14'th Mar 2024
Investors with an interest in Medical Services stocks have likely encountered both Icon PLC (ICLR) and Doximity (DOCS). But which of these two companies is the best option for those looking for underv
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
06:15am, Wednesday, 21'st Feb 2024
Doximity's stock is down over 70% from its all-time highs. However, its sales have more than doubled since its 2021 initial public offering.
Doximity, Inc. (DOCS) Q3 2024 Earnings Call Transcript
08:50pm, Thursday, 08'th Feb 2024
Doximity, Inc. (DOCS) Q3 2024 Earnings Call Transcript
Compared to Estimates, Doximity (DOCS) Q3 Earnings: A Look at Key Metrics
08:01pm, Thursday, 08'th Feb 2024
The headline numbers for Doximity (DOCS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates
06:11pm, Thursday, 08'th Feb 2024
Doximity (DOCS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.22 per share a year ago.
Countdown to Doximity (DOCS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Tuesday, 06'th Feb 2024
Get a deeper insight into the potential performance of Doximity (DOCS) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for
3 Stocks to Capitalize on the Telehealth Explosion
04:22pm, Monday, 08'th Jan 2024
The COVID-19 pandemic highlighted the sometimes fragile nature of the American healthcare system. Many people had to delay elective surgeries and forego other treatments for an extended period.
Doximity raised to ‘Neutral' as analysts see limited downside amidst macro challenges
02:04pm, Tuesday, 02'nd Jan 2024
Doximity Inc is well-positioned to meet and exceed expectations for fiscal 2024 after the online networking service for medical professionals cut its guidance and messaged slower growth, according to
